NovaBridge Biosciences (NBP) Debt to Equity (2018 - 2022)
NovaBridge Biosciences (NBP) has disclosed Debt to Equity for 3 consecutive years, with $0.01 as the latest value for Q4 2022.
- Quarterly Debt to Equity changed N/A to $0.01 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $0.01 through Dec 2022, changed N/A year-over-year, with the annual reading at $0.01 for FY2022, N/A changed from the prior year.
- Debt to Equity for Q4 2022 was $0.01 at NovaBridge Biosciences, up from -$0.02 in the prior quarter.
- The five-year high for Debt to Equity was $0.01 in Q4 2022, with the low at -$0.08 in Q4 2018.
- Average Debt to Equity over 3 years is -$0.03, with a median of -$0.02 recorded in 2019.
- Peak annual rise in Debt to Equity hit 70.66% in 2019, while the deepest fall reached 70.66% in 2019.
- Over 3 years, Debt to Equity stood at -$0.08 in 2018, then soared by 70.66% to -$0.02 in 2019, then soared by 126.51% to $0.01 in 2022.
- According to Business Quant data, Debt to Equity over the past three periods came in at $0.01, -$0.02, and -$0.08 for Q4 2022, Q4 2019, and Q4 2018 respectively.